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Abstract
Saccharomyces cerevisiae, the budding yeast was long history as industrial baker’s 
yeast due to its ability to produce numerous product such as ethanol, acetate, 
industrial bakers etc. Interestingly, this yeast was also important tools for studying 
biological mechanism in eukaryotic cells including aging, autophagy, mitochondrial 
response etc. S. cerevisiae has arisen as a powerful chemical and genetic screening 
platform, due to a rapid workflow with experimental amenability and the avail-
ability of a wide range of genetic mutant libraries. Calorie restriction (CR) as the 
reduction of nutrients intake could promote yeast longevity through some pathways 
such as inhibition of nutrient sensing target of rapamycin (TOR), serine–threonine 
kinase (SCH9), protein adenylate cyclase (AC), protein kinase A (PKA) and ras, 
reduced ethanol, acetic acid and apoptotic process. In addition, CR also induces the 
expression of antioxidative proteins, sirtuin2 (Sir2), autophagy and induction of 
mitochondrial yeast adaptive response. Three methods, spotting test; chronological 
life span (CLS) and replicative life span (RLS) assays, have been developed to study 
aging in S. cerevisiae. Here, we present strategies for pharmacological anti-aging 
screens in yeast, discuss common pitfalls and summarize studies that have used 
yeast for drug discovery.
Keywords: Saccharomyces cerevisiae, anti-aging, calorie restriction, spotting test, 
chronological life span, replicative life span
1. Introduction
The budding yeast Saccharomyces cerevisiae is unicellular eukariotic fungi that 
divide asexually by budding. This particular yeast cells has an individual cell size of 
5–10 μm and are pigmented, which cream color emerged in surface-grown colonies 
(Figure 1). Taxonomically, S. cerevisiae belongs to division of Ascomycota, class of 
Saccharomycetes, family of Saccharomycetaceae and genus of Saccharomyces. Yeast 
S. cerevisiae breaks down glucose in the medium through aerobic respiration in pres-
ence of oxygen. If oxygen is absent, the yeast will then undergo through anaerobic 
fermentation. This yeasts is widely distributed in the natural environment, 
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including soil, water, plants, animals, and insects. Notably, S. cerevisiae are 
eukaryotic cells that contain all major organelles that are also common to animal 
cells like nucleus, mitochondria, endoplasmic reticulum, vacuole, golgi apparatus, 
 cytoskeleton and many others organelles [1].
Scientist stated that S. cerevisiae was the first eukaryotic genome that was 
completely sequenced in 1996. In fact, the chromosomes of S. cerevisiae is com-
pactly organized on 16 chromosomes and the genome has about 12.156.677 base 
pairs with 6.275 genes along with about 5.800 are believed to be functionally genes. 
Interestingly, it is estimated that this particular yeast have at least 31% of its genes 
homologous with that of humans belonging [3, 4]. As for, mating between haploid 
cells must occur to return to the diploid state. Both of haploid and diploid phases 
are morphologically similar, but with larger cells for diploid. In the asexual repro-
duction, bud grows to reach the size of the mother cell while nuclear division hap-
pens [5]. The separation would process after a nucleus is passed to the daughter cells 
with the smaller size particularly than mother cells. S. cerevisiae has a long history 
of uses in the area of food processing as leavening for bread and as a fermenter of 
wine production and alcoholic beverages, along with as a vitamin supplement due 
to it contains 50% protein and is a rich source of niacin, folic acid and B vitamins. 
In addition, S. cerevisiae is also clearly stated as the most ideal eukaryotic cells for 
biological studies. The incredible power of yeast genetics has made a legendary tools 
and is the envy of those who work with higher eukaryotic organisms [4, 6].
On the other hand, aging is a multifaceted process of accumulation of cellular, 
molecular and organ damage, leading to loss of function and increased vulnerabil-
ity to disease following with the death. Indeed, there is a profound overlap between 
cellular and molecular pathways that influence aging and those linked to neurode-
generation, cancer, metabolic syndrome, and cardiovascular disorders. Therefore, 
recent efforts have emerged at the identification of compounds that decelerate the 
aging process and thus may act as a preventive measure that collectively ameliorates 
age-related diseases [7]. In fact, studies of aging in mammalian cells are limited by 
the long lifespan of common model organisms. Rats and mice live 3–5 years and 
primates up to 40. Nevertheless, aging studies, particularly in rodents, have been 
highly informative, of the prospective understanding of the genetic factors for 
modulating longevity [6]. Alternatively, a second approach that has dramatically 
accelerated aging research is the use of invertebrate model organisms, which age 
more rapidly and are readily amenable to environmental and genetic manipula-
tion. Even though a variety of organisms have been investigated, a majority of 
Figure 1. 
The budding yeast S. cerevisiae, (A) cells colony in agar plate medium; (B) cells morphology observed under 
microscope observation with 1000x magnification. Bars represent 5 μm. (picture permitted from [2], originally 
published in IOP Conf. Series: Earth and Environmental Science. doi: 10.1088/1755-1315/299/1/012059).
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studies have employed worms (Caenorhabditis elegans) [8], fruit flies (Drosophila 
melanogaster) [9], or yeast (S. cerevisiae) [10]. The use of model organisms at least 
in part due to its conserve some pathways that exist in all of these creatures, besides 
similarly in cellular or molecular events. One of the most popular conserve pathway 
is the nutrient-sensing pathway namely target of rapamycin (TOR) that exist in all 
of model organism starting from yeast to mammals [11].
The budding yeast S. cerevisiae has served as a model of organism and cellular 
aging for more than 50 years. In this particular yeast, many pathways that are 
relevant for aging and disease in humans are well conserved, including nutrient 
signaling, DNA repair mechanisms, cell cycle regulation, protein folding, lipostasis, 
mitochondrial homeostasis, stress response, secretion, proteostasis, and regulated 
cell death [6, 7]. In addition, the molecular mechanisms for cellular aging are also 
conserved from budding yeast to humans, primarily in particular condition with 
the nutrient depletion in growth medium, which retards aging and prolongs the 
lifespan. The conserved protein kinase, TORC1 (target of rapamycin complex 1), 
that is activated by nutrients and insulin, is a key regulator of the lifespan from 
eukaryotes organisms. The TORC1 inhibitor, namely rapamycin, retards aging and 
extends the lifespan of various species from yeast to mammals. In addition, this 
yeast has the advantages of speediness, simplicity, low cost, and good reproduc-
ibility. Furthermore, the genome DNA is not complex and has high homology with 
mammals. Indeed, all of DNA sequences are known and molecular mechanism 
research handling is relatively easy to perform, as well [6, 12, 13]. Some recent 
studies reported the utilization of S. cerevisase as a promising model organism 
to unravel anti-aging mechanism of compounds derived from various sources. 
Carmona-Gutierrez et al. [14] has shown anti-aging activity of flavonoid 4,4-dime-
thoxychalcone in S. cerevisiae by promoting authopagy mechanism. Lin et al., [15] 
reported anti-aging activity of Cucurbitacin B through regulating autophagy and 
oxidative stress in S. cerevisiae. In addition, Sudharsan et al., [16] also succeded to 
uncover the anti-aging mechanism of Astaxanthin in this yeast by decreasing oxida-
tive stress and apoptosis mechanisms.
In this brief chapter, we discussed the utilization of S. cerevisiae as a model 
organism in drug discovery research, and how this simple eukaryote has been 
employed not only as a production vehicle due to its capability to produce some 
products i.e. wine, alcoholic beverage, and proteins but also as a valuable tools 
in understanding biological aging. In fact, S. cerevisiae has a long history as the 
workhorse of pharmaceutical discovery research [17]. The uses of yeast explained 
in this chapter are including primary pathways involved in the mechanism of 
yeast aging belong to pro- or anti-aging mechanisms, and sections on the use of 
yeast for elucidating anti-aging compounds through the popular methods that was 
already utilized by previuos researcher’s. To this end, we would state that there are 
still limitation in regard with anti-aging study or review of using yeast as a model 
organism for elucidating anti-aging compounds in our country, Indonesia. At the 
same time, this country has an abundant sources of medicinal compounds derived 
from terestrial to aquatic regions. Therefore, we hope that this book chapter could 
provide new alternatively insight for pharamaceutical study focusing to discover 
active compounds with anti-aging properties.
2. Aging interventing mechanisms in S. cerevisiae
Biological aging in S. cerevisiae involved complicated mechanisms including, cel-
lular, physiological and molecular as well as intervented by environmental growth 
conditions. Interestingly, almost all of yeast model, particularly S. cerevisiae has 
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sophisticated response while growth in Calorie Restriction (CR) condition, which 
scientist’s oftenly used those phenomenon to learn aging pathway in yeast model. 
CR, a reduction in nutrient availability without malnutrition, is known to expand 
lifespan in a wide range of organisms from yeast to primates [11, 18]. Of note, 
deeply effort has been devoted to understanding the pathways that mediate the 
benefits of dietary restriction, since interventions that target these pathways may 
be effective in humans against the diseases of aging. In the yeast anti-aging assay, 
dietary restriction is usually generated by reducing glucose concentration from 2% 
to 0.5 or 0.05% in the growth culture [6], as well as restriction for amino acids has 
also been reported to exert lifespan [19].
Ultimately, CR reported could affect in some distinctive pathways in yeast cells. 
The first pathway is nutrient-sensing which reduced activity of two major nutrient 
sensing pathways, due to CR condition, could extend yeast life span. Both nutri-
ent sensing pathways are focused on an amino acid-sensing pathway, including 
the serine–threonine kinase SCH9 and the target of rapamycin (TOR). Notably, 
deletion or inhibition of SCH9 and TOR causes an increase of up to several fold in 
yeast life span. Alterations to reduce nutrient and protein synthesis in CR condi-
tion are strongly implicated in extension of yeast lifespan by reduced TOR/SCH9. 
Extension of yeast lifespan by reduced activity of the TOR pathway depends on 
the  transcription factor Gis1, which activates many protective systems including 
Mn-SOD [6, 20].
Further, the second pathway includes three proteins including adenylate cyclase 
(AC), protein kinase A (PKA), and Ras which will inhibit by CR conditions. The 
activation of two transcription factors (Msn2 and Msn4) that control cellular 
protection systems is required to mediate the effect of reduced Ras-AC-PKA signal-
ing on yeast lifespan extension. Extension of yeast lifespan by these pathways needs 
the antioxidant enzyme Mn-SOD (superoxide dismutase), which scavenges the 
superoxide free radical [11, 21]. Intriguingly, superoxide level increases during yeast 
aging and is reduced in yeast mutants deficient in Tor-SCH9 or Ras-AC-PKA signal-
ing. As for the yeast cells grow in the high glucose medium, could produce ethanol 
or acetic acid, which also contribute to chronological aging. Interestingly, deletion 
of SCH9 or TOR1 promotes removal of ethanol and acetic acid and accumulation of 
glycerol in the medium and further extend chronological life span by mechanisms 
similar to those of dietary restriction [22]. More importantly, decreased signaling 
by the Tor-SCH9 and Ras-AC-PKA pathways is important in response to glucose 
restriction as well as increased transcriptional activity of Msn2 and Msn4, and 
the consequent affecting the expression of Pnc1 [nicotinamide deaminase that 
promotes the activity of the nicotinamide adenine dinucleotide (NAD)- dependent 
deacetylase Sirtuin 2/Sir2]. The Sir2 have been extensively studied for their poten-
tial role as conserved modulators of anti-aging in a various of organisms, including 
mammals [23]. One mechanism by which Sir2 activity promotes yeast longevity 
is by suppressing homologous recombination in the rDNA that can promote the 
formation of extrachromosomal rDNA circles (ERCs). In fact, rDNA instability in 
general suggested the primary defect causing senescence and cell death [24].
Notably, another crucial mechanism that closely related with yeast aging is 
autophagy. This cellular process is reported as a highly conserved in organisms from 
yeast to human, which involves degradation of damaged organelles, circulation of 
amino acids, proteins, and other metabolites. It also regulates the genomic integrity 
via suppression of cell division in yeast under CR condition. Notably, decreased or 
dysfunction expression of autophagy genes leads to shorter lifespan in yeast and 
fruit fly. Conversely, enhanced autophagy promotes the longevity in aging models 
and suggested could protect against aging and age-related disorders [25, 26]. 
Another mechanisms which closely related with yeast aging is mitochondrial 
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adaptive response signaling. Mitochondrial organelle is known to have a basic role 
in aging and age-related diseases. This organelle contributes to the ATP production, 
cell homeostasis, and imbalanced reactive oxygen species (ROS) creating a basic 
role of the cells regulation [27]. In common condition, mitochondrial produces 
toxic ROS as by product of respiration process. However, on the CR condition, 
mitochondrial would be more active due to the shift metabolic process occurs from 
fermentation to respiration (CR) resulting ROS at the initial growth phases, as well. 
Consequently, yeast cells will adapt (pre-adaptation) with the ROS molecules strat-
ing from early growth stage and thus might activate defence mechanisms in the late 
of growth phase ensuring protection against higher doses of ROS. Those defence 
mechanisms likely activated antioxidative enzyme i.e. superoxide dismutase 
(SOD), catalase or glutathione peroxidase and therefore increase yeast lifespan 
(Figure 2) [28, 29].
Other than the above mechanisms in relation with CR condition resulting yeast 
lifespan extension. CR was also reported as having other substantial effects in yeast 
cells i.e. apoptotic process that accelerate aging process, repairing protein dam-
age, NAD+ homeostasis, vacuolar function, genome stability, ribosom biogenesis, 
proteolysis regulation, and cell hyperthrophy [30]. These valuable insights reflect 
that CR condition in yeast cells could modulate numerous pathways affected in 
biological aging mechanism. As for forefront anti-aging methods strategy, yeast 
cells growth on CR oftenly use as for positive control, whereas growing yeast cells 
on the normal growth medium with 2% glucose utilize as treatment for anti-aging 
compounds screening. If the yeast cells viability derived from compounds treat-
ment has similar or higher than positive control, it suggested that corresponding 
compounds have anti-aging activity in yeast cells. Further research usually applied 
to investigate the precise mechanisms which modulated by those promising anti-
aging compounds inside yeast cells.
3. Methods for investigating anti-aging activity in S. cerevisiae
On the basis of the current literatures, there were established various potential 
methods for investigating anti-aging activity derived from chemical compound by 
using S. cerevisiae as a model organism. It is including spotting test, Chronological 
Life Span (CLS) using Total Plate Count (TPC) analysis, Replicative Life Span 
(RLS) assay using microscopic observation, Propidium Iodida – Flow Cytometry 
Analysis (PI-FCA) analysis (see detail in Ocampo and Barrientos, 2011), Bac-light 
method (see detail in [31] Zhang and Fang, 2004), staining with methylen blue or 
phloxin B, physiological assay using luceferin reaction or rhodamine B (see detail in 
[32], and High-Throughput Rapid Chronological Lifespan (HTRCL) based on MTT 
Figure 2. 
(A) Some main pro-aging and (B) anti-aging pathways in S. cerevisiae. (TOR: target of rapamycin, SCH9: 
serine–threonine kinase, AC: Adenylate cyclase, PKA: Protein kinase A, SOD: Superoxide dismutase, Cat: 
Catalase, Gpx: Glutathione peroxidase).
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assay (See detail in [33]). However, in this section we would highlight only the most 
3 popular methods including spotting test, CLS, and RLS analysis.
3.1 Spotting test
This particular method is commonly used in order to observe the viability of S. 
cerevisiae cells through the phenotype spotting shape on the surface of solid growth 
medium. In fact, this method is also applied not only for S. cerevisiae, but also for other 
yeast to assay anti-aging activity of compounds, including Schizosaccharomyces pombe, 
Kluyveromyces lactis, Candida albicans, and Cryptococcus neoformans [7]. In addition, 
microbiologist oftenly utilize this method to search the specific microbial mutant that 
sensitive to particular conditions existing in the solid medium i.e. oxidative stress, 
antibiotic resistance, heat, osmotic, nutrient limitation, etc. Briefly, spot test was 
conducted by inoculating the fresh logarithmic S. cerevisae cells to the yeast liquid 
medium in the test tube with an appropriate initial OD600 of 0.05–0.1. Subsequently, 
the corresponding compound supplemented to the same yeast liquid medium with a 
certain concentration, and culture were incubated until reached the stationary phase 
(20–25 days) at the optimal growth temperature. Periodically, yeast treatment culture 
(usually at day 5, 10, 15, and 20) spotted to the yeast solid culture. As for the spotting 
test was initially performs by serially dilution of the treatment culture at the selected 
incubation time until 10−4 dilution value, then spotting applied from each dilution to 
the yeast solid medium. Further, the results are incubated for 3 days at the optimal 
growth temperature prior observed. The density of the grown cells from each spot is 
considered as the viability of S. cerevisiae cells (Figure 3) (see detail in [2, 34]).
Spotting test was reported as having some advantages in relation to assay 
anti-aging compounds including simple, fast handling and relatively low cost 
compare than CLS or other methods. However, this method could only represent a 
qualitative result of yeast cells viability through the yeast cells density, and thus it 
should be supported by other methods. As long as for the preliminary screening of 
numerous compounds acting as anti-aging, spotting method will be recommended. 
Some previous studies reported the usefulness of spot test to examine the particular 
compound for delaying aging in S. cerevisiae. Xiang et al., [35] was succeded to 
promote anti-aging mechanism in this yeast using phloridzin (an apple polyphenol) 
treatment. Apple extract, artemisinin, and roselle petal extract were also reported 
could increase S. cerevisiae lifespan using spotting test method [36–38]. Along with 
that, S. cerevisiae was succesfully used for obtaining the anti-aging activity of clove 
bud extract and some medicinal plant extract [2, 39].
Figure 3. 
Result of spotting test from clove bud extract using S. cerevisiae as model organism. Cells grown in yeast 
culture without extract addition (0 ppm) is designed as a control. The density of the grown cells from 
each spot considered as the viability of S. cerevisiae cells. Spotted at day 15 after treatment with 100 and 
200 ppm compound showed higher density than 0 ppm (control treatment), indicating anti-aging activity of 
corresponding compound to exert the yeast lifespan (picture permitted from [2], originally published in IOP 
Conf. Series: Earth and Environmental Science. doi: 10.1088/1755-1315/299/1/012059).
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3.2 CLS method using TPC analysis
CLS defines to the length of time a non-dividing cell can maintain viability, as 
refers to the its ability to re-enter the cell cycle process after a prolonged period of 
quiescence. Thus, CLS has been exhibited as a model of the viability of post-mitotic 
yeast cells [12]. Traditionally, CLS has been examined by culturing fresh logarith-
mic yeast cells on a particular flask until reached the stationary phase (20–25 days) 
in liquid culture with an appropriate initial OD600 of 0.05–0.1. As for compound 
treatment is applied to the liquid culture medium soon thereafter yeast innoculated. 
Further, the yeast cell survival is measured as a function of time by dilution and 
plating onto a nutrient-rich agar medium at the periodic time (i.e each 3 days). 
Subsequently, viability is then calculated on the basis of the number of colonies 
(colony forming units: CFUs) on the nutrient plate agar arising [40, 41]. The bud-
ding yeast S. cerevisiae reported entering a stationary/death phase after 20–25 days 
incubation [6]. Therefore, if compound treatment could prolong the yeast lifespan 
beyond 25 days, it suggested as the promising anti-aging materials. Of note, CLS 
assay is widely applied not only for S. cerevisiae but also for other yeast i.e. S. pombe 
or K. lactis for observing the bioactivity of prospective anti-aging compounds (i.e 
Figure 4, CLS applying in S. pombe).
Ultimately, CLS method requires a relatively large investment of materials, 
investigator time and belong to laborious, therefore is not suited for high-through-
put screening anti-aging compounds. However, through this particular method, it 
was obtained the quantitatively results and thus could provide deeply insight for 
representing the cell viability of the yeast cells. Numerous studies has been applied 
CLS method for assaying anti-aging compounds derived from multi-resources i.e. 
Nakaya et al., [42] assayed Beauveriolide I isolated from mushroom or Sunthonkun 
et al., [40] examined anti-aging of pigmented rice. In addition, other compounds 
including Dimethylchalcone, Cucurbitacin B, and Astaxanthine was exhibited anti-
aging activity in S. cerevisiae through CLS analysis [14–16].
3.3 RLS method
RLS assay is simple conceptually and shows an advantage of the fact that S. cere-
visiae cells divide by asymmetric budding, with the daughter cells that is produced 
Figure 4. 
CLS result using S. pombe (green line as a control treatment) after treatment with some compounds (red, 
orange, purple and yellow lines showed higher viability day than control treatment). In S.pombe, the 
stationary phase will reach after 13–15 days incubation at the optimal temperature (Prastya et al., 2020).
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being smaller than the mother cells of which it is derived. Daughter cells were 
isolated on a solid growth media and, once they started dividing, all daughter cells 
were removed. Longo (2012) founded that an individual cells do not divide forever, 
instead they would stop after a limited number of cells divisions (around of 20–25) 
and going to a short post-replicative state followed by death cells. The RLS method 
determines the number of daughters of a single mother cell, which can asexually 
produce prior to senescence. The mother-daughter cell asymmetry in S. cerevisiae 
cells can be easily observed under the light microscope, allowing the development 
of the RLS assay [6, 43].
As for RLS assay, the S. cerevisiae cells inoculated onto 5 mL galactose or glucose 
liquid medium and further incubated in a shaking incubator for 48 h at the optimal 
temperature. Subsequently, 1 mL of yeast cells culture was centrifuged and pellet 
washed with distilled water or phosphate buffer solution (PBS). After counting 
using a hemocytometer, 4000–5000 cells are plated on agar plates medium contain-
ing chemical compounds need to be assay for antiaging activity, and plates were 
further incubated for 2 days at the optimal temperature. The 40 microcolonies 
that formed on the agar plates were randomly observed under a microscope, and 
daughter cells were counted. Recently, S. cerevisase yeast cells reported as the most 
powerfull model organism for RLS analysis [44, 45]. The results of RLS assay 
usually show in the particular graphic that indicating the viability number from 
each generations of the yeast cells. If the viability of the yeast cells after compound 
treatment is higher than control treatment, it is indicating the potential anti-aging 
properties.
RLS method is reported as having some major weakness which it makes 
less effective for high-throughput approaches. It is including time-consuming, 
laborious and relatively intricate in technique due to applying microscopic cells 
observation prior for plating in the plate medium during assays. Nevertheless, 
this particular methods will devote precisely quntitatively results and thus could 
represent the number of yeast cells generation between control and anti-aging 
compound treatments. To date, some previous studies were reported for using 
S. cerevisiae RLS method to examine anti-aging compound derived from vari-
ous natural products, including Ganodermasides isolated from mushroom, or 
Hesperidin from citrus [46, 47]. Current studies were also informed anti-aging 
assay of some compounds i. e Parishin and Cucurbitacin B using S. cerevisiae RLS 
method, as well [15, 45].
4. Conclusions
Antiaging study in yeast was popular using CR condition which has numer-
ous response to prolong yeast lifespan. Aging pathway in CR belong to pro-and 
anti-aging pathways. As for pro-aging are including TOR, SCH9, Ras protein, AC, 
PKA, ethanol accumulation, and apoptotic process. On the other hand, anti-aging 
pathways are including induction of antioxidative enzymes, sirtuin2, autophagy 
and adaptive response thorough mitochondrial adaptive ROS signaling. CR condi-
tion usually use for positive control, while treatment conducted in non-CR/high 2% 
glucose medium. There are numerous methods for anti-aging study, which the most 
popular is spotting test, CLS and RLS assays.
Recently, anti-aging in S. cerevisiae research was developed sophisticated, 
derived from previous sources including natural compound derived from ter-
estrial or aquatic organism. In fact, other sources also potentially developed i.e. 
semisynthetic or synthetic compound as the preliminary screening for anti-aging 
compounds.
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Even the data from studies could be revisited and mined for potential bioactive 
substances, data obtained in yeast should not be over-interpreted unduly, and when 
aiming for applications in humans, validation of compounds in multicellular organ-
isms should be done. So far, the potential of yeast to unravel novel pharmacological 
interventions against aging is far-reaching, however that it will continue to contrib-
ute substantially not only to drug discovery but also in other field such as fermented 
food, biochemical and bioenergy production.
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